life sciences
-
Abhishek Kumar Singh Aug 16 2021 - 4 min readBiotechnology is the study of living organisms, especially those of different species. We can expand this definition to include all efforts to create second or subsequent generations of organisms, even those involving human beings. Biotech has had a tremendous impact on humankind: we have created entire organisms, such as bacteria and viruses, with the potential ...
-
Franchise India Bureau Jul 20 2019 - 1 min readAgilent Technologies Inc will acquire BioTek for $1.165 billion. Privately-owned BioTek is a global leader in the design, manufacture and distribution of innovative life science instrumentation. The company’s comprehensive product line consists of cell imaging systems, microplate readers, washers, dispensers, automated incubators and stackers. In the fiscal year 2018 ending December 31, BioTek garnered revenues of $162 million. It is ...
-
Franchise India Bureau Feb 15 2019 - 1 min readNavitas Life Sciences, a TAKE Solutions Enterprise, will acquire Life Sciences services player, DataCeutics, in North America. As part of the 2021 growth strategy, the acquisition spearheads the growth of Clinical business in accordance with the global Clinical market. This market is expected to reach $32.9 billion by 2020. Through this acquisition, Navitas Life Sciences ...
-
Franchise India Bureau Jan 14 2019 - 1 min readTAKE Solutions has agreed to buy two US-based companies operating in the life sciences space for a total consideration of $72 million. The Chennai-based company is acquiring health research firm KAI Research for $27 million and DataCeutics, clinical research and functional service provider, for $45 million, both in cash. Kai's acquisition will strengthen TAKE Solutions' ...
-
Franchise India Bureau Jul 09 2018 - 2 min readIndian agrochemical major UPL Ltd may acquire Arysta LifeScience, the agricultural pesticides business of NYSE-listed Platform Specialty Products Corp., for more than $4 billion. Citing three people aware of the development, the report said UPL is raising funds from a consortium of lenders to finance this deal. Arysta LifeScience focuses on the development, formulation, registration, ...